title: [Assessment of the treatment of glucocorticoid-induced osteoporosis].
abstract: Glucocorticoid-induced osteoporosis (GIOP) is known as a serious adverse side effect during long-term glucocorticoid treatment. Several clinical guidelines are available to whom and how we should start to treat GIOP. However, the assessment of the treatment of GIOP is still controversial. Accumulating evidences suggest us that both bone mineral density and bone turn over markers could reflect the effect of some pharmacological agents on bone metabolism. However, further studies would be required for precise assessment of the efficacy of drugs on fracture prevention in GIOP.
authors: Toyokawa City Hospital, Toyokawa, Aichi, Japan.
authors: Shogo
authors: S
authors: Asano
authors: Atsushi
authors: A
authors: Suzuki
mesh_terms: D015415:Biomarkers / Q000097:blood; D015519:Bone Density / Q000187:drug effects; D005938:Glucocorticoids / Q000009:adverse effects*; D006801:Humans; D010024:Osteoporosis / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D058866:Osteoporotic Fractures / Q000139:chemically induced / Q000188:drug therapy / Q000517:prevention & control; D017410:Practice Guidelines as Topic
chemical_list: D015415:Biomarkers; D005938:Glucocorticoids